Physical Medicine & Rehabilitation, Pain Medicine · San Francisco, CA
NPI
1659397917
Since 2006
Specialty
Physical Medicine & Rehabilitation, Pain Medicine
Code 2081P2900X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4141 Geary Blvd Fl 2, Chronic Pain Management
San Francisco, CA, 94118
Phone (415) 833-4621
Groups this clinician bills Medicare through
Medicare paid, 2023
$578
16 services
Medicare patients, 2023
11
Average age 63
Drug cost, 2024
$312K
4,466 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Georgi Mikeladze prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 968 prescriptions and refills. In total Georgi Mikeladze wrote 4,466 Medicare prescriptions that cost $312K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-09.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 968 | 968 | 140 | $32K |
| Morphine Sulfate Er Morphine Sulfate | 625 | 625 | 92 | $30K |
| Oxycodone Hcl Generic | 558 | 558 | 76 | $12K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 474 | 474 | 68 | $14K |
| Gabapentin Generic | 218 | 358 | 43 | $6,423 |
| Methadone Hcl Generic | 203 | 203 | 29 | $7,922 |
| Duloxetine Hcl Generic | 196 | 315 | 52 | $2,616 |
| Oxycontin Oxycodone Hcl | 180 | 180 | 27 | $106K |
| Tramadol Hcl Generic | 150 | 150 | 22 | $1,527 |
| Hydromorphone Hcl Generic | 112 | 112 | 24 | $4,746 |
| Pregabalin Generic | 93 | 117 | 28 | $1,575 |
| Morphine Sulfate Generic | 92 | 92 | 24 | $1,783 |
| Fentanyl Generic | 56 | 56 | Under 11 | $14K |
| Acetaminophen-Codeine Acetaminophen With Codeine | 48 | 48 | 12 | $2,709 |
| Buprenorphine Generic | 43 | 43 | Under 11 | $7,386 |
Brand drugs: 261 claims; generic drugs: 4,205 claims; opioid claims: 3,530.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Georgi Mikeladze were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.